Coreline Soft unveils AVIEW 2.0 at RSNA 2025: next generation AI platform redefining radiology workflow standards
Coreline Soft will unveil AVIEW 2.0 at RSNA 2025 showcasing a unified AI platform that integrates lung cancer screening, coronary artery calcium scoring, and COPD quantification into one continuous diagnostic workflow. Clinical validation demonstrates 89 per cent faster case throughput and 60 per cent reduction in interpretation time—consolidating multi-disease CT assessment into a single automated pipeline.
Proven at global scale AVIEW has processed over 2.5 million cases across 19 countries, establishing itself as proven medical infrastructure rather than experimental technology. The platform serves as the standard AI solution for government-led lung cancer screening programs in Germany, France, and Italy.
As European nations issue guidelines recommending AI as mandatory in screening workflows, this validation signals a fundamental market shift toward AI as essential infrastructure.
US clinical adoption
Major US institutions have integrated AVIEW into daily operations. UMass Memorial Medical Center deployed the platform for comprehensive thoracic screening across LCS, CAC, and COPD diagnosis, while Temple Lung Center, 3DR Labs, and ImageCare Radiology have incorporated AVIEW into research and diagnostic workflows—demonstrating real-world adaptability to diverse clinical environments.
Infrastructure, not add-on
“AI’s value is no longer theoretical,” said James Lee, COO of Coreline North America. “AVIEW 2.0 delivers a sustainable foundation for precision medicine at scale.” With national-scale European validation, top-tier US adoption, and 2.5 million global cases, Coreline Soft positions AVIEW 2.0 as the new benchmark where efficiency, accuracy, and scalability converge in AI-driven thoracic imaging.
Visit Coreline Soft at RSNA 2025 on stand 4929 South Hall.
This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine. Visit our dedicated RSNA conference page to find out more.
